Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2014

01-11-2014 | Clinical trial

Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center

Authors: Mehra Golshan, Katya Losk, Sarah Kadish, Nancy U. Lin, Judith Hirshfield-Bartek, Linda Cutone, Yasuaki Sagara, Fatih Aydogan, Kristen Camuso, Saul N. Weingart, Craig Bunnell

Published in: Breast Cancer Research and Treatment | Issue 1/2014

Login to get access

Abstract

Few studies have examined care processes within providers’ and institutions’ control that expedite or delay care. The authors investigated the timeliness of breast cancer care at a comprehensive cancer center, focusing on factors influencing the time from initial consultation to first definitive surgery (FDS). The care of 1,461 women with breast cancer who underwent surgery at Dana-Farber/Brigham and Women’s Cancer Center from 2011 to 2013 was studied. The interval between consultation and FDS was calculated to identify variation in timeliness of care based on procedure, provider, and patients’ sociodemographic characteristics. Targets of 14 days for lumpectomy and mastectomy and 28 days from mastectomy with immediate reconstruction were set and used to define delay. Mean days between consultation and FDS was 21.6 (range 1–175, sd 15.8) for lumpectomy, 36.7 (5–230, 29.1) for mastectomy, and 37.5 (7–111, 16) for mastectomy with reconstruction. Patients under 40 were less likely to be delayed (OR = 0.56, 95 % CI = 0.33–0.94, p = 0.03). Patients undergoing mastectomy alone (OR = 2.64, 95 % CI = 1.80–3.89, p < 0.0001) and mastectomy with immediate reconstruction (OR = 1.34 95 % CI = 1.00–1.79, p = 0.05) were more likely to be delayed when compared to lumpectomy. Substantial variation in surgical timeliness was identified. This study provides insight into targets for improvement including better coordination with plastic surgery and streamlining pre-operative testing. Cancer centers may consider investing in efforts to measure and improve the timeliness of cancer care.
Literature
1.
go back to reference Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79(5–6):858–864PubMedCrossRefPubMedCentral Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79(5–6):858–864PubMedCrossRefPubMedCentral
2.
go back to reference Smith EC, Ziogas A, Anton-Culver H (2013) Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 148(6):516–523PubMedCrossRef Smith EC, Ziogas A, Anton-Culver H (2013) Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 148(6):516–523PubMedCrossRef
3.
go back to reference Desch CE, McNiff KK, Schneider EC et al (2008) American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 26(21):3631–3637PubMedCrossRef Desch CE, McNiff KK, Schneider EC et al (2008) American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 26(21):3631–3637PubMedCrossRef
4.
go back to reference Institute of Medicine, Committee on Quality of Health Care in America (2011) Improving the 21st-century health care system-six aims for improvement. In: Crossing the Quality Chasm: a new health system for the 21st century. National Academy Press, Washington, DC, pp 53–54 Institute of Medicine, Committee on Quality of Health Care in America (2011) Improving the 21st-century health care system-six aims for improvement. In: Crossing the Quality Chasm: a new health system for the 21st century. National Academy Press, Washington, DC, pp 53–54
5.
go back to reference Wright GP, Wong JH, Morgan JW, Roy-Chowdhury S, Kazanjian K, Lum S (2010) Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment. Am Surg 76(10):1119–1122PubMed Wright GP, Wong JH, Morgan JW, Roy-Chowdhury S, Kazanjian K, Lum S (2010) Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment. Am Surg 76(10):1119–1122PubMed
6.
go back to reference Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN (2011) Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 37:568–575PubMed Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN (2011) Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 37:568–575PubMed
7.
go back to reference Ramirez AG, Perez-Stable EJ, Talavera GA et al (2013 Dec) Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study. Springerplus. 2(1):84PubMedCrossRefPubMedCentral Ramirez AG, Perez-Stable EJ, Talavera GA et al (2013 Dec) Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study. Springerplus. 2(1):84PubMedCrossRefPubMedCentral
8.
go back to reference Plotogea A, Chiarelli A, Mirea L, Prummel M et al (2013) Factors associated with wait times across the breast cancer treatment pathway in Ontario. Springerplus 2(388):1–9 Plotogea A, Chiarelli A, Mirea L, Prummel M et al (2013) Factors associated with wait times across the breast cancer treatment pathway in Ontario. Springerplus 2(388):1–9
9.
go back to reference Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H (2002) Patient delay and stage of diagnosis among breast cancer patients in Germany—a population based study. Br J Cancer 86(7):1034–1040PubMedCrossRefPubMedCentral Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H (2002) Patient delay and stage of diagnosis among breast cancer patients in Germany—a population based study. Br J Cancer 86(7):1034–1040PubMedCrossRefPubMedCentral
10.
go back to reference Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M (1994) Patient’s and doctor’s delay in primary breast cancer. Acta Oncol. 33(4):345–351PubMedCrossRef Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M (1994) Patient’s and doctor’s delay in primary breast cancer. Acta Oncol. 33(4):345–351PubMedCrossRef
11.
go back to reference Landercasper J, Linebarger JH, Ellis RL et al (2010) A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg 210(4):449–455PubMedCrossRef Landercasper J, Linebarger JH, Ellis RL et al (2010) A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg 210(4):449–455PubMedCrossRef
12.
go back to reference Sue GR, Lannin DR, Killelea B, Tsangaris T, Chagpar AB (2013) Does time to definitive treatment matter in patients with ductal carcinoma in situ? Am Surg 79(6):561–565PubMed Sue GR, Lannin DR, Killelea B, Tsangaris T, Chagpar AB (2013) Does time to definitive treatment matter in patients with ductal carcinoma in situ? Am Surg 79(6):561–565PubMed
13.
go back to reference Stone MD, Norton S, Mendez JE, Hirsch E (2007) Positive impact of a breast-health training system on breast-care access and physician satisfaction. Am J Surg 194(4):482–487PubMedCrossRef Stone MD, Norton S, Mendez JE, Hirsch E (2007) Positive impact of a breast-health training system on breast-care access and physician satisfaction. Am J Surg 194(4):482–487PubMedCrossRef
14.
go back to reference Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen N (2010) Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery 148(4):746–751PubMedCrossRef Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen N (2010) Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery 148(4):746–751PubMedCrossRef
15.
go back to reference Tseng JF, Kronowitz SJ, Sun CC et al (2004) The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 101(7):1514–1523PubMedCrossRef Tseng JF, Kronowitz SJ, Sun CC et al (2004) The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 101(7):1514–1523PubMedCrossRef
Metadata
Title
Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center
Authors
Mehra Golshan
Katya Losk
Sarah Kadish
Nancy U. Lin
Judith Hirshfield-Bartek
Linda Cutone
Yasuaki Sagara
Fatih Aydogan
Kristen Camuso
Saul N. Weingart
Craig Bunnell
Publication date
01-11-2014
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2014
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3124-2

Other articles of this Issue 1/2014

Breast Cancer Research and Treatment 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine